SCHEMBL5770692

SCHEMBL5770692

[CH2]CC(C)CC(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3392036 0.83 ALDH1A1 (0.38)
Acetamide SCHEMBL4103797 0.78 LMNA (0.47)
SCHEMBL11413659 0.78 ECE1 (0.35)
SCHEMBL5755727 0.76
SCHEMBL20520329 0.76
SCHEMBL96279 0.76
SCHEMBL3377572 0.76
SCHEMBL5049546 0.76
SCHEMBL276778 0.76
SCHEMBL96280 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1706410-A2 PYRROLOPYRIMIDINE AND PYRROLOTRIAZINE DERIVATIVES AS CRF RECEPTOR ANTAGONISTS TAISHO PHARMACEUTICAL CO., LTD (JP) 2006-10-04 EP disclosed
WO-2005066142-A2 PYRROLOPYRIMIDINE AND PYRROLOTRIAZINE DERIVATIVES AS CRF RECEPTOR ANTAGONISTS TAISHO PHARMACEUTICAL CO., LTD. (JP) 2005-07-21 WO disclosed
EP-1330429-A2 ALKYNYL AMIDES AND THEIR THERAPEUTIC APPLICATIONS Abbott Laboratories (US) 2003-07-30 EP disclosed
WO-2002036546-A2 ALKYNYL AMIDES AND THEIR THERAPEUTIC APPLICATIONS ABBOTT LABORATORIES (US) 2002-05-10 WO disclosed